Detalhe da pesquisa
1.
Antibacterial and Cytotoxic Study of Hybrid Films Based on Polypropylene and NiO or NiFe2O4 Nanoparticles.
Int J Mol Sci
; 24(23)2023 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38069375
2.
Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2-metastatic breast cancer receiving single-agent chemotherapy-a comparison with MONARCH 1.
Breast Cancer Res Treat
; 184(1): 161-172, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32789591
3.
SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer.
Future Oncol
; 16(24): 1801-1813, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32633563
4.
Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors.
Eur J Cancer Care (Engl)
; 27(4): e12861, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29869823
5.
RAGE/SNAIL1 signaling drives epithelial-mesenchymal plasticity in metastatic triple-negative breast cancer.
Oncogene
; 42(35): 2610-2628, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468678
6.
The conundrum of breast cancer and microbiome - A comprehensive review of the current evidence.
Cancer Treat Rev
; 111: 102470, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36283165
7.
Circulating SOD2 Is a Candidate Response Biomarker for Neoadjuvant Therapy in Breast Cancer.
Cancers (Basel)
; 14(16)2022 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36010852
8.
Prognostic value of ctDNA detection in patients with early breast cancer undergoing neoadjuvant therapy: A systematic review and meta-analysis.
Cancer Treat Rev
; 104: 102362, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219090
9.
GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells.
Cancers (Basel)
; 14(10)2022 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35626166
10.
Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response.
Ther Adv Med Oncol
; 14: 17588359221139601, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36479470
11.
Epstein-Barr Virus+ B Cells in Breast Cancer Immune Response: A Case Report.
Front Immunol
; 12: 761798, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34868006
12.
Neoadjuvant Model as a Platform for Research in Breast Cancer and Novel Targets under Development in this Field.
Breast Care (Basel)
; 13(4): 251-262, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30319327
13.
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2- Metastatic Breast Cancer.
Clin Cancer Res
; 23(17): 5218-5224, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533223
14.
18F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial.
Clin Cancer Res
; 23(6): 1432-1441, 2017 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27587436
15.
Critically short telomeres and toxicity of chemotherapy in early breast cancer.
Oncotarget
; 8(13): 21472-21482, 2017 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28423524
16.
Bone metastases with nerve root compression as a late complication in patient with epithelial pleural mesothelioma.
J Thorac Dis
; 5(2): E35-7, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23585954
17.
Pyoderma vegetans associated with severe psoriatic arthritis: good response to etanercept.
Dermatology
; 214(1): 77-81, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17191052